Site Management Organization (SMO)

A Site Management Organization (SMO) is a company that provides staff, infrastructure, and administrative support directly to clinical trial sites — helping investigators and site staff conduct the operational, day-to-day work of a trial. This distinguishes an SMO from a Contract Research Organization (CRO), which contracts with the trial sponsor to manage some or all of a trial across potentially many sites. The two vendor types are sometimes confused because both are outsourced clinical-trial service providers, but they sit on different sides of the sponsor-site relationship and are not interchangeable.

What an SMO Actually Provides

SMOs typically supply some combination of the following directly to a site or investigator practice:

• Clinical research coordinator (CRC) staffing. Trained CRCs who handle participant visits, source documentation, and day-to-day protocol adherence at the site level — often the largest single line item an SMO provides, since qualified CRC staffing is a persistent bottleneck for many independent sites and physician practices.
• Regulatory and administrative support. Assembling and maintaining the regulatory binder, IRB submission paperwork, informed consent tracking, and other documentation a site must keep current across every active protocol.
• Study start-up assistance. Site-side feasibility assessment, contract and budget negotiation support, and the administrative work of getting a site activated for a new protocol.
• Patient recruitment support at the site level. Local recruitment and pre-screening against a protocol’s eligibility criteria — see CASRAI’s Clinical Trial Patient Recruitment guide for the broader recruitment process this feeds into; an SMO’s role here is narrower and site-specific, not the sponsor-level recruitment strategy the guide covers as a whole.
• Physical and technical infrastructure. Exam space, equipment, and sometimes the clinical trial management system (CTMS) or eSource tools a site uses, particularly for SMOs that operate dedicated research sites rather than supporting an existing physician practice.

Two SMO Business Models

Industry usage of “SMO” covers two related but distinct models, and the label is applied to both:

• Site-support model. The SMO contracts with an existing independent physician practice or academic investigator, supplying staff and administrative infrastructure so that practice can take on trial work without building a dedicated research operation of its own. The practice remains the site; the SMO is a services vendor to it.
• Site-network model. The SMO owns and directly operates a network of dedicated clinical research sites under its own management, standardizing processes, staffing, and systems across every site in the network. In this model the SMO effectively is the site organization for sponsors and CROs to contract with, offering consistent operational quality and often faster activation across multiple locations at once.

SMO vs. CRO: The Core Distinction

Dimension	SMO	CRO
Contracts with	Investigator, site, or physician practice (sometimes a CRO or sponsor engages one on a site’s behalf)	The trial sponsor
Scope	Operations at one site or a network of sites the SMO manages	Trial-wide functions that can span every site in a study, plus functions with no site presence at all (biostatistics, regulatory submissions, pharmacovigilance)
Formal regulatory definition	None — an industry/business-model term	Defined in ICH E6(R2) Section 5.2 and, for FDA-regulated drug/biologic trials, 21 CFR 312.52
Can assume sponsor regulatory obligations by written transfer	No — an SMO is not a party to the sponsor’s regulatory delegation framework	Yes, per 21 CFR 312.52 and ICH E6(R2) §5.2

The regulatory-status distinction is the sharpest line between the two. As covered in CASRAI’s CRO entry, a CRO’s identity as a CRO for a given trial is a function of a written contract transferring specific sponsor obligations to it under ICH E6(R2)/21 CFR 312.52 — with the sponsor retaining ultimate accountability regardless of what’s delegated. An SMO sits outside that delegation framework entirely: it is not named in ICH E6 or FDA regulation as a category that can assume sponsor obligations, because its relationship runs to the site or investigator rather than to the sponsor.

How an SMO Differs from a Pure Recruitment Vendor

An SMO’s site-level recruitment support (above) is only one of several services it provides, layered on top of staffing and infrastructure — it is not a recruitment-only vendor. A company that exclusively provides participant recruitment and advertising services, without supplying site staffing, regulatory support, or infrastructure, is functioning as a recruitment vendor rather than an SMO. See CASRAI’s Clinical Trial Patient Recruitment guide for the full set of recruitment channels and how they are evaluated, independent of which type of vendor — SMO, dedicated recruitment company, or the site’s own staff — executes them.

Illustrative Examples

The following are illustrative composites, not descriptions of specific named companies.

• A four-physician independent cardiology practice wants to participate in industry-sponsored trials but has no dedicated research staff. It contracts with an SMO, which places a CRC and a regulatory coordinator on-site, trains the practice’s front-desk staff on pre-screening, and manages the regulatory binder across the practice’s active protocols. The practice itself remains the trial site; the SMO is its staffing and administrative vendor.
• A sponsor’s CRO needs to activate 40 sites quickly for a phase III trial in a therapeutic area with limited investigator density. It contracts with a site-network SMO that operates a standardized network of dedicated research sites in the target region, achieving faster activation and more consistent site-level performance than recruiting and onboarding 40 independent practices individually.

Counter-Example: What Is Not an SMO

A full-service CRO that a sponsor contracts to manage an entire multi-site trial — including monitoring, data management, and regulatory submissions — is not an SMO, even though it interacts extensively with sites, because its contractual relationship runs to the sponsor and it is operating under the ICH E6(R2)/21 CFR 312.52 delegation framework. Likewise, a company that provides only patient-recruitment advertising and call-center screening services, with no site staffing or infrastructure component, is a recruitment vendor rather than an SMO.